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األسباب املتعددة اللتواء ختطيط القلب حول النقطة يف مريض جراحي 
داخل املستشفى
بر�صانث باندوراجنا، حممد املخيني، مامثا راجاراو
امللخ�ص: رجل يف ال55 من العمر معروف باإدمان الكحول وم�صاب بفريو�ض نق�ض املناعة الب�رسية مت اإدخاله اإىل جناح اجلراحة بعد 
ت�رسيف خراج العجان. مت اكت�صاف وجود بطء يف اجليب القلبي، جممعات البطني املبكرة وانخفا�ض �صغط الدم اخلفيف. النتائج املخربية 
بينت وجود نق�ض خفيف ببوتا�صيوم الدم. املري�ض كان م�صطرب ب�صكل متقطع ومت ت�صخي�صه مبتالزمة �صحب الكحول. بعد اجلراحة ح�صل 
املري�ض عن طريق احلقن الوريدي علي البيربا�صيلني/تازوباكتام واملرتانيدزول بالإظافة اىل جرعة �صغرية من الدوبامني. اأظهر حتليل 
جهاز مراقبة هولرت 24 �صاعة )ECG( على فا�صل QT مطول مع حالتني لإلتواء تخطيط القلب حول النقطة ذاتية الإنتهاء. مت عالج 
متالزمة �صحب الكحول، ت�صحيح نق�ض بوتا�صيم الدم و�صحب الدوبامني وامل�صادات احليوية. مل يكن هناك تكرار لإ�صطراب النظم القلبي. 
هذه احلالة �صلطت ال�صوء على اأهمية جتنب الأدوية التي ت�صبب اإطالة فا�صل QT يف املر�صى املدخلني للم�صت�صفيات اإذ اإنه غالبا ما يكون 
املر�صى لديهم عوامل خطر متعددة ل�صطراب النظم املحر�ض. 
الكحول، بفريو�ض نق�ض  QT، متالزمة �صحب  اإطالة  اأدوية   ،  QT اإطالة   ،  QT النقطة، فا�صل  القلب حول  التواء تخطيط  الكلمات:  مفتاح 
املناعة الب�رسية، عمان. 
abstract: A 55-year-old chronic alcoholic male known to be positive for human immunodeficiency virus (HIV) 
was admitted to a surgical ward following perianal abscess drainage. He was noted to have sinus bradycardia, 
ventricular premature complexes, and mild hypotension. His laboratory investigations revealed mild hypokalaemia. 
He was intermittently agitated and alcohol withdrawal syndrome (AWS) was diagnosed. Postoperatively, he received 
intravenous piperacillin/tazobactam and metronidazole infusions along with a small dose of dopamine. Analysis of 
a 24-hour Holter monitor (ECG) showed a prolonged QT interval with two episodes of self-terminating torsade de 
pointes. His AWS was treated, hypokalaemia was corrected, and dopamine, along with antibiotics, was withdrawn. 
There was no recurrence of arrhythmias. This case highlights the importance of avoiding QT-prolonging drugs 
in hospitalised patients, since hospitalised patients often have multiple risk factors for a proarrhythmic response. 
Keywords: Torsade de pointes; QT interval; QT prolongation; QT-prolonging drugs; Alcohol withdrawal syndrome; 
Human immunodeficiency virus; Case report; Oman.
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case report
Drug-induced QT prolongation and torsade de pointes (TdP) with cardiac arrest is a rare but potentially fatal event 
in hospital settings.1 We present a patient with TdP 
in whom the aetiology was multifactorial.
Case Report
A 55-year-old non-diabetic, non-hypertensive male 
was admitted to the surgical ward at the Royal 
Hospital, Muscat, Oman, following perianal abscess 
drainage surgery. He was referred to a cardiologist 
for sinus bradycardia, ventricular premature 
complexes (VPCs), and mild hypotension, which 
were not present pre-operatively. He was not 
on any regular medications but was receiving 
regular doses of piperacillin/tazobactam and 
metronidazole infusions as antibiotics along with 
a dopamine infusion of 5 μg/kg/minute post-
operatively. No cardiovascular symptoms were 
described. His past medical history had included 
chronic alcoholism and human immunodeficiency 
virus (HIV) positivity but he was without any 
history of substance abuse. An examination 
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demonstrated anxiety, agitation, tremors, and 
excessive sweating, but no cardiovascular issues 
or other abnormalities. There were no episodes 
of seizure, hallucination, or delirium tremens. His 
serum potassium level was 2.9 mmol/L. Other 
routine blood tests, including amylase, troponin T, 
calcium, sodium, and magnesium were normal. His 
baseline electrocardiogram (ECG) showed a sinus 
rhythm of 60 beats/minute, and narrow normal 
QRS complexes with few uniform VPCs, and a 
normal corrected QT interval (QTc). 
A diagnosis of alcohol withdrawal syndrome 
(AWS) was made and treated with oral diazepam. 
He was also given intravenous (IV) fluids with 
potassium supplementation. His transthoracic 
echocardiography was normal. A 24-hour 
ambulatory Holter monitor ECG  showed an 
intermittently prolonged QTc interval (QTc, Bazett’s 
correction = 470 ms) along with two episodes of self-
terminating non-sustained torsade de pointe (TdP) 
ventricular tachycardia [Figure 1]. The first episode 
lasted 6 seconds and the second episode lasted 11 
seconds. There were no ST-segment changes noted. 
The nursing staff on the ward were unaware of these 
arrhythmias. His dopamine and antibiotics were 
withdrawn. The patient's symptoms settled within 
72 hours and the rest of his stay was uneventful. His 
discharge serum potassium level was 4.9 mmol/L 
with no VPCs or TdP on telemetry monitoring. The 
patient also had a normal QTc interval.
Discussion
The role of alcohol in causing heart failure 
(alcoholic cardiomyopathy) and supraventricular 
arrhythmias, especially atrial fibrillation (holiday 
heart syndrome)  is well-known.2 TdP is a form of 
polymorphic ventricular tachycardia associated 
with a prolonged QT interval (either congenital 
or acquired). QT prolongation is known to occur 
in AWS.3,4 Otero-Anton et al. documented a 
prolonged QTc interval in 46% of patients studied 
and Cuculi et al. in 63% of patients who had AWS, 
with two patients developing TdP, but without 
any pre-treatment with QT-prolonging drugs.3,4 
However, our patient was treated with piperacillin/
tazobactam and metronidazole, which have 
recently been discovered to cause TdP.5 Cuculi et 
al. opined that QT prolongation may be due to 
autonomous system disturbances in AWS.3 This 
was demonstrated in recent experimental studies 
involving rats.6,7 Abrupt termination of the chronic 
ethanol intake in rats increased heart rate variability 
and QT interval dispersion, suggesting impaired 
homogeneity of myocardial repolarisation and a 
shift of the cardiac sympathovagal balance toward 
sympathetic predominance and reduced vagal tone. 
The mechanism for most QT-prolonging drugs 
is inhibition of the KCNH2-encoded human ether-
à-go-go related gene (hERG) potassium channel 
which mediates IKr (rapid component of the 
delayed rectifier potassium current), although some 
drugs mainly modify sodium channels.8 Inhibition 
of this current results in prolongation of myocardial 
repolarisation/action potential duration along with 
a prolonged QT interval as well as changes in T-U 
wave morphology. There is a graded increase in 
the risk for TdP as the QTc increases. Specifically, 
each 10-millisecond (msec) increase in QTc leads 
to an approximate 5–7% increase in a patient’s risk 
for developing TdP.1 There is no threshold of QTc 
prolongation at which TdP is certain to occur. In 
this patient, TdP occurred at a mildly prolonged 
 
Figure 1: Electrocardiogram rhythm strips from 
a 24-hour ECG (Holter monitor) showing self-
terminating non-sustained torsade de pointes in a 
patient with alcohol withdrawal syndrome and human 
immunodeficiency virus infection receiving dopamine 
and QT-prolonging antibiotics.
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QTc interval. However, small studies of drug-
induced TdP have shown an increased risk when the 
threshold of QTc >500 msec is exceeded.1 The onset 
of TdP is pause-dependent and is precipitated by 
either bradycardia, in which sudden long cycles may 
lead to arrhythmogenic early afterdepolarisations, 
or by premature beats that lead to short-long-
short cycles.1 Both these factors were seen in this 
patient. The trigger for TdP is a VPC that results 
from an early afterdepolarisation generated during 
the abnormally prolonged repolarisation phase of 
the affected myocardium.1 Because of the extreme 
delay of repolarisation in certain regions of the 
myocardium, conduction of the VPC is blocked 
initially in some directions but not in others, which 
sets up re-entry that perpetuates TdP. 
Although in the majority of cases prolonged 
myocardial repolarisation caused by drugs is 
clinically silent, when prescribed in the setting 
of other risk factors, it may lead to TdP as seen 
in this patient. In-hospital risk factors for TdP 
include female gender, advanced age, electrolyte 
derangements (hypokalaemia, hypomagnesaemia, 
hypocalcaemia), treatment with diuretics, 
underlying heart disease, rapid IV infusion, use 
of more than one QT-prolonging drug (including 
various antipsychotics, antidepressants, antibiotics, 
antiemetics, antihistaminics, inotropes, and 
class IA and III antiarrhythmics), hepatic and/
or renal failure, pharmacokinetic/pharmaco- 
dynamic interactions, occult congenital long 
QT syndrome, genetic polymorphisms, and 
bradycardia.1,8 This patient had five risk factors for 
TdP. These included acute AWS, HIV infection, 
bradycardia, hypokalaemia, and treatment with 
three QT-prolonging drugs (dopamine, piperacillin/
tazobactam, and metronidazole). HIV infection has 
been shown to be an independent risk factor for QT 
prolongation. Kocheril et al. reported a prevalence 
of QT prolongation in 28% of hospitalised HIV 
patients.9 In the recent HIV-infection and heart 
disease (HIV-HEART) study, the prevalence was 
20%.10 Yang et al. have demonstrated that the IKr-
blocking properties of certain drugs is directly 
dependent on extracellular potassium.11 They 
showed anincreasing drug block of the potassium 
current precipitated by hypokalaemia. This was an 
important mechanism to explain the link between 
hypokalaemia and TdP.11 Analysing data from 
the United States Food and Drug Administration 
(USFDA) Adverse Event Reporting System, Poluzzi 
et al. reported additional drugs that can cause QT 
prolongation and TdP, which included piperacillin/
tazobactam and metronidazole.5 Management 
of TdP includes correction of any predisposing 
factors, such as hypokalaemia, and cessation of any 
predisposing medication. Acute treatment includes 
electrical (DC) cardioversion if haemodynamically 
compromised, defibrillation if TdP degenerates into 
ventricular fibrillation, IV magnesium (first-line 
therapy), and isoprenaline or temporary ventricular 
overdrive pacing to augment the heart rate. 
Conclusion 
In conclusion, this case highlights the importance 
of avoiding QT-prolonging drugs in hospitalised 
patients, since hospitalised patients often have 
multiple risk factors for a proarrhythmic response. 
In addition, this case reiterates the recent American 
Heart Association/American College of Cardiology 
Foundation (AHA/ACCF) scientific statement 
to raise awareness among acute care physicians, 
managing such patients in hospital units, about 
the multiple risk factors, ECG monitoring, and 
management of drug-induced long QT syndrome 
(LQTS).1
References
1. Drew BJ, Ackerman MJ, Funk M, Gibler WB, Kligfield 
P, Menon V, et al. American Heart Association Acute 
Cardiac Care Committee of the Council on Clinical 
Cardiology; Council on Cardiovascular Nursing; 
American College of Cardiology Foundation. 
Prevention of torsade de pointes in hospital settings: 
A scientific statement from the American Heart 
Association and the American College of Cardiology 
Foundation. J Am Coll Cardiol 2010; 55:934–47.
2. Laonigro I, Correale M, Di Biase M, Altomare E. 
Alcohol abuse and heart failure. Eur J Heart Fail 
2009; 11:453–62. 
3. Cuculi F, Kobza R, Ehmann T, Erne P. ECG changes 
amongst patients with alcohol withdrawal seizures 
and delirium tremens. Swiss Med Wkly 2006; 136: 
223–7.
4. Otero-Anton E, Gonzalez-Quintela A, Saborido J, 
Torre JA, Virgos A, Barrio E. Prolongation of the 
QTc interval during alcohol withdrawal syndrome. 
Acta Cardiol 1997; 52:285–94.
5. Poluzzi E, Raschi E, Motola D, Moretti U, De Ponti 
F. Antimicrobials and the risk of torsade de pointes: 
The contribution from data mining of the USFDA 
Prashanth Panduranga, Mohammed Al-Mukhaini and Mamatha P. Rajarao
Case Report | 155
Adverse Event Reporting System. Drug Saf 2010; 
33:303–14.
6. Shirafuji S, Liu J, Okamura N, Hamada K, Fujimiya 
T. QT interval dispersion and cardiac sympathovagal 
balance shift in rats with acute ethanol withdrawal. 
Alcohol Clin Exp Res 2010; 34:223–30.
7. Liu J, Fujimiya T. Abrupt termination of an ethanol 
regimen provokes ventricular arrhythmia and 
enhances susceptibility to the arrhythmogenic 
effects of epinephrine in rats. Alcohol Clin Exp Res 
2010; 34:S45–53. 
8. van Noord C, Eijgelsheim M, Stricker BH. Drug- and 
non-drug-associated QT interval prolongation. Br J 
Clin Pharmacol 2010; 70:16–23.  
9. Kocheril AG, Bokhari SA, Batsford WP, Sinusas 
AJ. Long QTc and torsade de pointes in human 
immunodeficiency virus disease. Pacing Clin 
Electrophysiol 1997; 20:2810–16.
10. Reinsch N, Buhr C, Krings P, Kaelsch H, Neuhaus K, 
Wieneke H, et al. German Heart Failure Network. 
Prevalence and risk factors of prolonged QTc interval 
in HIV-infected patients: Results of the HIV-HEART 
study. HIV Clin Trials 2009; 10:261–8.
11. Yang T, Roden DM. Extracellular potassium 
modulation of drug block of IKr. Implications for 
torsade de pointes and reverse use-dependence. 
Circulation 1996; 93:407–11.
